Categories: Health

Molecular mechanism characterizing colorectal cancer

Research published in the journal Journal of Experimental and Clinical Cancer Researchshows that blocking the binding between CDH17/DSC1 proteins will provide a new strategy to combat metastatic dissemination in patients with metastatic colorectal cancer.

“Taken together, these results shed new light on multiple functions of cadherin protein 17 (CDH17) in colorectal cancer metastasis and identification of new therapeutic targets“, says the researcher Ignacio Casalfrom the Margarita Salas Biological Research Center (CSIC), who led the study.

The combination of CDH17 and desmocholine 1 (DSC1) proteins plays a key role in the metastasis (or spread of tumor cells to form tumors in other organs) of colorectal cancer. “Our studies showed that CDH17, a key player in promoting colorectal cancer metastasis, can bind to DSC1, a desmosomal protein regulate migration and invasion in colorectal cancer tumors

mesenchymal or poorly differentiated,” says Casal.

DSC1 protein silencing

“Proteomic analysis and animal models in natural conditions allowed us to demonstrate that the DSC1/CDH17 complex causes the recruitment of p120-catenin through the cytoplasmic domain of DSC1,” explains the researcher. “Immunohistochemical analyzes have demonstrated that DSC1 is expressed at high levels at the invasive tumor front in colorectal cancer biopsies, suggesting that DSC1 stabilizes the formation of groups of migrating cells and possibly circulating tumor cells (CTCs),” he adds.

The researchers observed that the suppression of the DSC1 protein in metastatic mesenchymal colorectal cancer cells reaches greater survival rate of treated mice, by inhibiting localization in the liver during metastasis.

Moreover, the authors demonstrate that the NLV sequence in CDH17 is a possible binding motif used by CDH17 to bind DSC1. The synthetic NLV peptide blocked the binding of CDH17 to DSC1, inhibiting cancer cell migration, invasion and metastasis.

These results open the door to the development of new therapeutic strategies for the treatment of metastatic colorectal cancer.

Scientific link:

Ruben A. Bartolome, Laura Pintado-Berninches, Angela Martín-Regalado, Javier Robles, Tania Calvo-López, Marina Ortega-Sapero, Celia Llorente-Sáez, Issam Bukic, Maria Jesús Fernández-Aceñero, and J. Ignacio Casal. The complex of cadherin 17 with desmocollin 1 and p120-catenin regulates colorectal cancer migration and invasion according to cellular phenotype.

. (2024) J Exp Clin Cancer Res. https://doi.org/10.1186/s13046-024-02956-6

Fountain: CSIC

Source link

Admin

Share
Published by
Admin

Recent Posts

“Emilia Perez,” a musical comedy about Mexican drug traffickers based on a script by Audiard.

This is the film "Markants of the last Cannes Film Festival", which features four actresses:…

42 mins ago

They attack the US aircraft carrier in the Arabian Sea with missiles and drones

CAIRO - Yemen's Houthi rebels said on Tuesday that they had carried out Two military…

45 mins ago

The Community of Madrid is delivering over 440,000 MiraCoredor electronic glucose monitors free of charge to diabetic patients.

The head of the region invested 20 million euros in these devices. The Madrid community…

47 mins ago

Lopesan disembarks in the financial center of Madrid

The largest hotel group in the Canary Islands comes to Madrid and does so in…

54 mins ago

Spanish developer Tequila Works declares bankruptcy

Madrid studio Tequila Works has declared bankruptcy and begun bankruptcy proceedings. The latest game published…

56 mins ago

Mark Cucalon, Arbeloa’s gem, retires at 19 due to cursed bacteria | Relief

796 days after the injury in Glasgow, in the Youth League match between Celtic and…

58 mins ago